Regulatory compliant software for mutation analysis in clinical diagnostics

SIGNify

is in vitro medical device software intended for identification of somatic mutations in cancer from single tumor sample.

The software consists of read-trimmer, read-aligner and variant caller for reporting base substitutions, small insertions and deletions in next-generation sequencing data from a tumor sample.

For more information on licensing and use of our products, please contact us.

Reach us here